Empresas Iansa S.A (IANSA)
Chilean Stock Exchange · Chile · prices in CLP · close of 22 Oct 2026
Key indicators
| Last close | CLP 26.20 |
|---|---|
| 52-week range | 23.45 – 44.40 |
| Return, 1 month / 3 months | +0.0% / −17.6% |
| Return, 1 year / 3 years | −3.4% / +86.1% |
| Trend | Below its 200-day average |
| RSI (14) | 19 |
| Volatility (1 year) | 37.3% |
| Worst drawdown (1 year) | -41.2% |
| Average daily value traded | 0.70M CLP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Empresas Iansa is a Chilean agro-industrial company based in Santiago that produces sugar and sugar-derived products. It processes sugar beet grown by contracted farmers and also refines imported raw cane sugar, supplying refined sugar to food and beverage manufacturers, retailers and industrial customers. The company also makes animal feed and other agricultural products, and its operations are tied closely to Chile's farming regions and the domestic food industry.
Empresas Iansa S.A trades under the code IANSA on the Chilean Stock Exchange in Chile, with its price quoted in Chilean pesos (CLP). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Empresas Iansa S.A (IANSA) trades on the Chilean Stock Exchange in Chile. It last closed at CLP 26.20 on 22 October 2026.
Its price-based Market X-Ray is 10 out of 100 (a weak price profile), ranking 110 of 112 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.4% and over the last three months it fell 17.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Chilean Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 6 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.1% | ||
| From 52-week high | -40.7% | ||
| Momentum | 11 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.6% | ||
| 6-month return | -28.3% | ||
| 12-month return, skipping the last month | -3.4% | ||
| Stability (higher is calmer) | 12 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.2% | ||
| Liquidity | 13 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.70M CLP | ||
| Zero-volume days | 6.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | −17.6% |
| 6 months | −28.3% |
| 1 year | −3.4% |
| 3 years | +86.1% |
| 5 years | +70.3% |
Signals
| 50-day / 200-day average | 26.13 / 32.79 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 May 2025 | CLP 0.1589 |
| 6 May 2024 | CLP 0.8408 |
| 12 May 2023 | CLP 0.0305 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Chilean Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.